Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[HIV-infection and pregnancy: what is the best form of delivery?].
Gingelmaier A, Kästner R, Bolten M, Weizsäcker K. Gingelmaier A, et al. Among authors: weizsacker k. MMW Fortschr Med. 2012 May 16;154 Suppl 1:20, 22, 24. MMW Fortschr Med. 2012. PMID: 22916593 Review. German. No abstract available.
Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy.
Blonk MI, Colbers AP, Hidalgo-Tenorio C, Kabeya K, Weizsäcker K, Haberl AE, Moltó J, Hawkins DA, van der Ende ME, Gingelmaier A, Taylor GP, Ivanovic J, Giaquinto C, Burger DM; Pharmacokinetics of Newly Developed Antiretroviral Agents in HIV-Infected Pregnant Women PANNA Network; PANNA Network. Blonk MI, et al. Among authors: weizsacker k. Clin Infect Dis. 2015 Sep 1;61(5):809-16. doi: 10.1093/cid/civ366. Epub 2015 May 5. Clin Infect Dis. 2015. PMID: 25944344 Clinical Trial.
Lowered Rilpivirine Exposure During the Third Trimester of Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women.
Schalkwijk S, Colbers A, Konopnicki D, Gingelmaier A, Lambert J, van der Ende M, Moltó J, Burger D; Pharmacokinetics of newly developed antiretroviral agents in HIV-infected pregnant women (PANNA) Network. Schalkwijk S, et al. Clin Infect Dis. 2017 Oct 15;65(8):1335-1341. doi: 10.1093/cid/cix534. Clin Infect Dis. 2017. PMID: 28595298 Clinical Trial.
Pharmacokinetics of total and unbound darunavir in HIV-1-infected pregnant women.
Colbers A, Moltó J, Ivanovic J, Kabeya K, Hawkins D, Gingelmaier A, Taylor G, Weizsäcker K, Sadiq ST, Van der Ende M, Giaquinto C, Burger D; PANNA Network. Colbers A, et al. Among authors: weizsacker k. J Antimicrob Chemother. 2015 Feb;70(2):534-42. doi: 10.1093/jac/dku400. Epub 2014 Oct 17. J Antimicrob Chemother. 2015. PMID: 25326090 Clinical Trial.
Atazanavir exposure is effective during pregnancy regardless of tenofovir use.
Colbers A, Hawkins D, Hidalgo-Tenorio C, van der Ende M, Gingelmaier A, Weizsäcker K, Kabeya K, Taylor G, Rockstroh J, Lambert J, Moltó J, Wyen C, Sadiq ST, Ivanovic J, Giaquinto C, Burger D; PANNA network. Colbers A, et al. Among authors: weizsacker k. Antivir Ther. 2015;20(1):57-64. doi: 10.3851/IMP2820. Epub 2014 Jul 3. Antivir Ther. 2015. PMID: 24992294 Clinical Trial.
[Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents - A Guideline on Behalf of the German Society for Pediatric Infectious Diseases (DGPI)].
Feiterna-Sperling C, Brinkmann F, Adamczick C, Ahrens F, Barker M, Berger C, Berthold LD, Bogyi M, von Both U, Frischer T, Haas W, Hartmann P, Hillemann D, Hirsch FW, Kranzer K, Kunitz F, Maritz E, Pizzulli A, Ritz N, Schlags R, Spindler T, Thee S, Weizsäcker K. Feiterna-Sperling C, et al. Among authors: weizsacker k. Pneumologie. 2017 Oct;71(10):629-680. doi: 10.1055/s-0043-116545. Epub 2017 Oct 10. Pneumologie. 2017. PMID: 29017219 Free article. German.
33 results